Assembly Biosciences, Inc.ASMBNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +2.71% | +62.82% | +12.81% | +57.62% |
| Gross Profit Growth | +0.00% | -197.80% | +63.72% | -176.45% | +57.62% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +45.00% | +20.03% | +36.89% | +35.68% | +20.54% |
| Weighted Average Shares Diluted Growth | +45.00% | +20.03% | +36.89% | +35.68% | +20.54% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -100.55% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -100.55% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +830.23% | -100.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +94.20% | -13.31% | -17.41% | -29.95% | +139.37% |
| Book Value per Share Growth | -57.01% | -32.38% | -39.20% | -61.53% | +482.88% |
| Debt Growth | +56.91% | +31.90% | +55.99% | +65.18% | +91.05% |
| R&D Expense Growth | +24.86% | +29.75% | +25.02% | -0.82% | +22.73% |
| SG&A Expenses Growth | +1.47% | -46.56% | -2.04% | +3.35% | +18.64% |